Gonadotropin combination therapy

1 marketed 1 in Phase 3

This page covers all Gonadotropin combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FSH receptor (FSHR); estrogen receptor (ER) antagonism, FSH receptor and LH receptor.

Targets

FSH receptor (FSHR); estrogen receptor (ER) antagonism · FSH receptor and LH receptor

Marketed (1)

Phase 3 pipeline (1)